ABK Biomedical

company

About

ABK Biomedical combines the clinical market with biomaterials with a focus on treating hypervascular tumors.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$9.44M
Industries
Biotechnology,Health Care,Medical,Medical Device
Founded date
Jan 1, 2012
Number Of Employee
11 - 50
Operating Status
Active

ABK Biomedical combines the clinical market with biomaterials. It specializes in improving treatment options for patients with hypervascular tumors.

The company is dedicated to transforming an interventional radiology procedure called embolization.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$9.44M
ABK Biomedical has raised a total of $9.44M in funding over 2 rounds. Their latest funding was raised on Jun 22, 2016 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 22, 2016 Series A $9.44M 1 Detail
Jan 1, 2014 Angel 1 Detail
Sep 15, 2012 Seed 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
ABK Biomedical is funded by 2 investors. Innovacorp and Wilmington Investor Network are the most recent investors.
Investor Name Lead Investor Funding Round
Innovacorp Series A
Wilmington Investor Network Angel